184 related articles for article (PubMed ID: 27163234)
1. Antiangiogenic or Corticosteroid Treatment in Patients With Radiation Maculopathy After Proton Beam Therapy for Uveal Melanoma.
Seibel I; Hager A; Riechardt AI; Davids AM; Böker A; Joussen AM
Am J Ophthalmol; 2016 Aug; 168():31-39. PubMed ID: 27163234
[TBL] [Abstract][Full Text] [Related]
2. Radiation-Induced Optic Neuropathy: Observation versus Intravitreal Treatment: Can Visual Acuity Be Maintained by Intravitreal Treatment?
Eckstein D; Riechardt AI; Heufelder J; Zeitz O; Böker A; Brockmann C; Joussen AM; Seibel I
Am J Ophthalmol; 2019 Dec; 208():289-294. PubMed ID: 31323201
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal triamcinolone acetate for radiation maculopathy recalcitrant to high-dose intravitreal bevacizumab.
Kaplan RI; Chaugule SS; Finger PT
Br J Ophthalmol; 2017 Dec; 101(12):1694-1698. PubMed ID: 28416492
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal dexamethasone 0.7-mg implant for radiation macular edema after proton beam therapy for choroidal melanoma.
Baillif S; Maschi C; Gastaud P; Caujolle JP
Retina; 2013 Oct; 33(9):1784-90. PubMed ID: 23652581
[TBL] [Abstract][Full Text] [Related]
5. Radiation Maculopathy After Proton Beam Therapy for Uveal Melanoma: Optical Coherence Tomography Angiography Alterations Influencing Visual Acuity.
Matet A; Daruich A; Zografos L
Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):3851-3861. PubMed ID: 28763558
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
Sheth S; Rush R; Natarajan S; Gillies M
Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
[TBL] [Abstract][Full Text] [Related]
7. Treatment of radiation maculopathy with intravitreal injection of bevacizumab (Avastin).
Gupta A; Muecke JS
Retina; 2008; 28(7):964-8. PubMed ID: 18698298
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal triamcinolone versus intravitreal bevacizumab in the treatment of exudative retinal detachment secondary to posterior uveal melanoma.
Parrozzani R; Pilotto E; Dario A; Miglionico G; Midena E
Am J Ophthalmol; 2013 Jan; 155(1):127-133.e2. PubMed ID: 22995029
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study.
Finger PT; Chin KJ; Semenova EA
Eur J Ophthalmol; 2016; 26(1):60-6. PubMed ID: 26391167
[TBL] [Abstract][Full Text] [Related]
10. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.
Seibel I; Cordini D; Hager A; Tillner J; Riechardt AI; Heufelder J; Davids AM; Rehak M; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1787-92. PubMed ID: 27376824
[TBL] [Abstract][Full Text] [Related]
11. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal triamcinolone acetonide for radiation maculopathy after plaque radiotherapy for choroidal melanoma.
Shields CL; Demirci H; Dai V; Marr BP; Mashayekhi A; Materin MA; Manquez ME; Shields JA
Retina; 2005; 25(7):868-74. PubMed ID: 16205566
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal triamcinolone acetonide for acute radiation papillopathy.
Shields CL; Demirci H; Marr BP; Mashayekhi A; Dai VV; Materin MA; Shields JA
Retina; 2006; 26(5):537-44. PubMed ID: 16770260
[TBL] [Abstract][Full Text] [Related]
14. INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT AT 2-MONTH INTERVALS REDUCES FOVEAL AVASCULAR ZONE ENLARGEMENT AND VISION LOSS IN RADIATION MACULOPATHY: A Pilot Study.
Daruich A; Matet A; Schalenbourg A; Zografos L
Retina; 2019 Aug; 39(8):1519-1526. PubMed ID: 29746413
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema due to central retinal vein occlusion.
Wu WC; Cheng KC; Wu HJ
Eye (Lond); 2009 Dec; 23(12):2215-22. PubMed ID: 19218991
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma.
Shah SU; Shields CL; Bianciotto CG; Iturralde J; Al-Dahmash SA; Say EAT; Badal J; Mashayekhi A; Shields JA
Ophthalmology; 2014 Jan; 121(1):269-275. PubMed ID: 24139123
[TBL] [Abstract][Full Text] [Related]
17. THE OMAR STUDY: Comparison of Ozurdex and Triamcinolone Acetonide for Refractory Cystoid Macular Edema in Retinal Vein Occlusion.
Ozkok A; Saleh OA; Sigford DK; Heroman JW; Schaal S
Retina; 2015 Jul; 35(7):1393-400. PubMed ID: 25748280
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal dexamethasone implant in radiation-induced macular oedema.
Frizziero L; Parrozzani R; Trainiti S; Pilotto E; Miglionico G; Pulze S; Midena E
Br J Ophthalmol; 2017 Dec; 101(12):1699-1703. PubMed ID: 28404670
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic Intravitreal Bevacizumab After Plaque Radiotherapy for Uveal Melanoma: Analysis of Visual Acuity, Tumor Response, and Radiation Complications in 1131 Eyes Based on Patient Age.
Chang M; Dalvin LA; Mazloumi M; Martin A; Yaghy A; Yang X; Bakhtiari S; Li L; Jennings E; Mashayekhi A; Shields CL
Asia Pac J Ophthalmol (Phila); 2020; 9(1):29-38. PubMed ID: 31990743
[TBL] [Abstract][Full Text] [Related]
20. INTRAVITREAL DEXAMETHASONE IMPLANT FOR RADIATION MACULOPATHY SECONDARY TO PLAQUE BRACHYTHERAPY IN CHOROIDAL MELANOMA.
Caminal JM; Flores-Moreno I; Arias L; Gutiérrez C; Piulats JM; Català J; Rubio MJ; Cobos E; García P; Pera J; Giralt J; Arruga J
Retina; 2015 Sep; 35(9):1890-7. PubMed ID: 26035401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]